Rivaroxaban and apixaban are Factor Xa (FXa) inhibitor oral anticoagulants that are used to treat and prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation, deep vein thrombosis and pulmonary embolism. The gene discussed is F10; the disease is pulmonary embolism.